YolantaTKruszynskaMD

PubMed

• 10 citations
  Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
  Yolanta T. Kruszynska, Jerrold M. Olefsky, Juan P. Frias> ;Metabolism. 2003 Feb 1
• 577 citations
  The Effect of Thiazolidinediones on Plasma Adiponectin Levels in Normal, Obese, and Type 2 Diabetic Subjects
  Joseph G. Yu, Sandrine Javorschi, Andrea L. Hevener, Yolanta T. Kruszynska, Rodney A. Norman, Madhur K. Sinha, Jerrold M. Olefsky> ;Diabetes. 2002 Oct 1
• 128 citations
  Fatty Acid-Induced Insulin Resistance: Decreased Muscle PI3K Activation But Unchanged Akt Phosphorylation
  Yolanta T. Kruszynska, Dorothy Sears Worrall, Jachelle M. Ofrecio, Juan P. Frias, Gina Macaraeg, Jerrold M. Olefsky> ;The Journal of Clinical Endocrinology and Metabolism. 2002 Jan 1
• 116 citations
  Decreased Susceptibility to Fatty Acid–Induced Peripheral Tissue Insulin Resistance in Women
  Juan P. Frias, Gina Macaraeg, Jachelle M. Ofrecio, Joseph G. Yu, Jerrold M. Olefsky, Yolanta T. Kruszynska> ;Diabetes. 2001 Jun 1
• 144 citations
  Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
  Yolanta T. Kruszynska, Joseph G. Yu, Jerrold M. Olefsky, Burton E. Sobel> ;Diabetes. 2000 Apr 1
• 40 citations
  Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia.
  Boris Draznin, Philip D.G. Miles, Yolanta T. Kruszynska, Jerrold M. Olefsky, Jacob E. Friedman, Inga Golovchenko, Richard Stjernholm, Kei Wall, Marc L. Reitman, Domeni...> ;Endocrinology. 2000 Apr 1
• 39 citations
  Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
  Juan P. Frias, Joseph G. Yu, Yolanta T. Kruszynska, Jerrold M. Olefsky> ;Diabetes Care. 2000 Jan 1
• 79 citations
  A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
  Joseph G. Yu, Yolanta T. Kruszynska, Mim I. Mulford, Jerrold M. Olefsky> ;Diabetes. 1999 Dec 1
• 65 citations
  Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
  Yolanta T. Kruszynska, Mim I. Mulford, J Baloga, Joseph G. Yu, Jerrold M. Olefsky> ;Diabetes. 1998 Jul 1
• 16 citations
  Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients
  Yolanta T. Kruszynska, Spiros Goulas, Nigel Wollen, Neil McIntyre> ;Journal of Hepatology. 1998 Feb 1
• 68 citations
  Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus.
  Yolanta T. Kruszynska, R Mukherjee, L Jow, S Dana, J R Paterniti, Jerrold M. Olefsky> ;The Journal of Clinical Investigation. 1998 Feb 1
• 38 citations
  Effects of Nonesterified Fatty Acids on Glucose Metabolism After Glucose Ingestion
  Yolanta T. Kruszynska, Mim I. Mulford, Joseph G. Yu, Debra Armstrong, Jerrold M. Olefsky> ;Diabetes. 1997 Oct 1
• 109 citations
  Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus.
  Yolanta T. Kruszynska, Jerrold M. Olefsky> ;Journal of Investigative Medicine. 1996 Oct 1
• 8 citations
  Lipid metabolism and insulin resistance in cirrhosis.
  G Kaye, Yolanta T. Kruszynska, David S. Harry, Kirsten Heslop, Desmond G. Johnston, Neil McIntyre> ;Journal of Hepatology. 1994 Jan 1
• Lack of effect of a physiological elevation of plasma non-esterified fatty acid levels on insulin secretion.
  Frias, J. P., Basabe, L., Macaraeg, G., Kruszynska, Y. T.> ;Diabetes Metab. 2000 Apr
• Acute effects of central neuropeptide Y injection on glucose metabolism in fasted rats.
  Wilding, I. P., Kruszynska, Y. T., Lambert, P. D., Bloom, S. R.> ;Clin Sci. 1995 Nov
• Acute hyperinsulinemia increases neuropeptide Y concentrations in the hypothalamic arcuate nucleus of fasted rats.
  Malabu, U. H., Cotton, S. J., Kruszynska, Y. T., Williams, G.> ;Life Sci. 1993
• Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients.
  Kruszynska, Y. T., Harry, D. S., Bergman, R. N., McIntyre, N.> ;Diabetologia. 1993 Feb
• Metabolic handling of orally administered glucose in cirrhosis.
  Kruszynska, Y. T., Meyer-Alber, A., Darakhshan, F., Home, P. D., McIntyre, N.> ;J Clin Invest. 1993 Mar
• Insulin resistance in high fat fed rats. Role of glucose transporters, membrane lipids, and triglyceride stores.
  Fryer, L. G., Kruszynska, Y. T.> ;Ann N Y Acad Sci. 1993 Jun 14
• Energy expenditure and substrate metabolism after oral fructose in patients with cirrhosis.
  Kruszynska, Y. T., Meyer-Alber, A., Wollen, N., McIntyre, N.> ;J Hepatol. 1993 Sep
• Lipid metabolism and substrate oxidation during intravenous fructose administration in cirrhosis.
  Kruszynska, Y. T., Harry, D. S., Fryer, L. G., McIntyre, N.> ;Metabolism. 1994 Sep
• The contribution of proinsulin and des-31,32 proinsulin to the hyperinsulinemia of diabetic and nondiabetic cirrhotic patients.
  Kruszynska, Y. T., Harry, D. S., Mohamed-Ali, V., Home, P. D., Yudkin, J. S., McIntyre, N.> ;Metabolism. 1995 Feb
• Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis.
  Kruszynska, Y. T., Ghatei, M. A., Bloom, S. R., McIntyre, N.> ;Hepatology. 1995 Apr
• Alternative routes and methods of insulin delivery.
  Home, P. D., Gill, G. V., Husband, D., Kruszynska, Y. T., Marshall, S., Alberti, K. G.> ;Neth J Med. 1985 Jan 01
• Join now to see all